Cardiac Diagnostics
This channel includes news, videos, podcasts and other content on new technology innovations for cardiac diagnostic systems and techniques. This includes laboratory testing, blood tests including troponin testing, electrocardiogram (ECG) systems, point of care testing systems, genetic testing, cardiac patient monitoring devices including wearable sensors, and studies showing new ways to diagnose heart diseases.
Feature | ACC | April 09, 2020 | Dave Fornell, Editor
Here is the list of American College of Cardiology (ACC) practice-changing late-breaking study presentations at the ACC...
Cardiologists who have experience with COVID-19 patients in New York City say a low threshold should be used to assess patients for cardiogenic shock in the setting of acute systolic heart failure related to COVID-19. If inotropic support fails in these patients, researchers suggest use of an IABP (intra-aortic balloon pump) as the first line mechanical circulatory support device, because it requires the least maintenance from medical support staff.
News | Coronavirus (COVID-19) | April 08, 2020 | Dave Fornell, Editor
April 8, 2020 — Research to help increase awareness of the cardiovascular manifestations of COVID-19 disease and the...
A CDC image of the novel coronavirus (COVID-10) SCAI and CAIC have created a registry to investigate the cardiovascular impact of the virus.
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of...
Sponsored Content
Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.
Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.
News | Cardiac Imaging | April 03, 2020
April 3, 2020 — Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not...
Women carry heavier burden of chest pain, but less artery narrowing, according to data in a substudy from the ISCHEMIA Trial.
News | Womens Cardiovascular Health | March 28, 2020
March 28, 2020 — Women with coronary artery disease that reduces blood flow and oxygen to the heart muscle (ischemia)...
Naveen Pereira, M.D., co-principal investigator of the TAILOR-PCI study, explaining the conclusions of the late-breaking trial data during the virtual ACC20 meeting.
News | Antiplatelet and Anticoagulation Therapies | March 28, 2020
March 28, 2020 — The TAILOR-PCI trial that used genetic testing to guide which antiplatelet medication was given to...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
Videos | FFR Technologies | March 26, 2020
James Udelson, M.D., chief of the division of cardiology, Tufts Medical Center, explains how cardiac computed...
Hydroxychloroquine causes prolonged QT intervals and cardiac arrhythmias, so this needs to be considered in patients being treated with this drug for COVID-19.
Feature | Coronavirus (COVID-19) | March 24, 2020 | Marianne Pop, Pharm.D, BCPS
It has been more than three months since the word coronavirus was uttered on everyone’s lips and all over the social...
Feature | Coronavirus (COVID-19) | March 20, 2020 | Dave Fornell, Editor
March 20, 2020 — The Centers for Medicare and Medicaid Services (CMS) announced March 18, 2020, that all elective...
Sponsored Content
Use of traditional Holter monitor leads can be an issue for patient compliance and comfort. The newer generation ambulatory cardiac monitors use a small, adhesive patch that sticks directly on the patient's chest and allows them to shower and go about daily activities without a belt mounted monitor or leads getting in the way. This is especially important for longer term monitoring of seven days or longer.
Feature | ECG | September 27, 2018
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the...
Videos | Coronavirus (COVID-19) | March 20, 2020
An interview with Ehtisham Mahmud, M.D., FSCAI, chief, Division of Cardiovascular Medicine, executive director of...
News | Cardiovascular Business | March 17, 2020
March 17, 2020 — The Trump Administration today announced expanded Medicare telehealth coverage that will enable...
Videos | Coronavirus (COVID-19) | March 17, 2020
Interview with Thomas Maddox, M.D., MSc, FACC, the chairman of the American College of Cardiology (ACC) Science and...
Sponsored Content
An example of an automated summary cardiac monitor report from Medicalgorithmics' PocketECG system. Most of the the report parameters can be opened as separate pages with additional automated report summaries and graphical data charts.
Blog | Remote Monitoring | June 20, 2018
There is a movement toward real-time, remote cardiac monitoring with the latest generation of event and Holter monitor...
OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.
Feature | ECG | March 11, 2020
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness...
The COVID-19 mortality rate for patients cardiovascular disease is 10.5 percent based of data from Chinese hospitals since the outbreak. COVID-19 fatality rates for patients with comorbidities are higher than the average population, but cardiac patients had the highest death rate.
Feature | Coronavirus (COVID-19) | March 09, 2020
March 9, 2020 — The American College of Cardiology (ACC) is offering updates on the clinical impact of novel...
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.
News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the...
